CD19/BCMA CAR T-cells
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy. (NCT06733610) | Institute of Hematology & Blood Diseases Hospital, China | 2024-12-05 |
Track CD19/BCMA CAR T-cells automatically
Every clearance here is in the API, with alerts when new ones post.